418
1021308020012657111168
www.iakardiologie.cz48438040010765133201214233274312354380428447495515563613632675690730769
PŘEHLEDOVÉ341200012660124182256312369444520587645
ČLÁNKY1008200012660115187259327395
/1424200012633
REVIEW1477200012662121191224282376
ARTICLES1874200012668131191224287342399458
Kombinace34136001063372126162180221261294326
beta-blokátoru6833600106336699136162198229268304346374413449490
a1189360010638
inhibitoru12433600106155697114150168200239274315
ACE157436001063871103
v1693360010636
léčbě17453600106296196132164
hypertenze192536001063976111143179210242284317349
a2289360010638
jejích2343360010622548198133174
komplikací253336001063372126161191209245287320337
25.340550085367387
Knuuti4485500833574112150172188
J,6565500832436
Wijns713550083577489127153
W,8875500835767
Saraste975550083326586119146169203
A,11995500834155
et12745500833457
al.1351550083324760
201914325500833468100130
ESC15835500833367107
Guidelines1711550083438297136171187202240275302
for340650083185677
the430650083226094
diagnosis537650083385385124162200226241267
and8176500833169108
management9386500835789127159198233290325363384
of13356500833756
chronic1404650083316990127165180212
coronary1629650083316889126165197218251
syndromes.1893650083265997340750083385997155190217231
Eur591750083336990
Heart7027500834479111132157
J.8797500832437
Jan936750083245795
1410517500833465
2020;41(3):407-477.11377500833468101135148183213228262279291325361394413449481516522
doi:10.1093/1680750083387691104133165177208240275308332
eurheartj/ehz425.340850083347293131166198219244259286317355385418450485497
26.340950085367288
von4499500833270109
Arnim5789500834163102117176
T.7749500833342
Medical8379500835590130146178211227
treatment1084950083224478110132191226265287
to13919500832259
reduce1471950083215595133166200
total1691950083225982115130
ischemic184295008315417411214734010500835772104
burden:4601050083387798136171209221
total6961050083225981114129
ischemic8411050083144072110145203218250
burden11071050083387798136171209
bisoprolol13311050083395581119159180217233271287
study16341050083264987126158
(TIBBS),18071050083195571107143175194205
a340115008332
multicenter38711500835795110132148180213251273307328
trial728115008321435890106
comparing84711500833168126165198219235272311
bisoprolol11711150083395581119158180217233271287
and147111500833270109
nifedipine.15931150083375271106145160199215253288300
The190611500833272107
TIBBS3401250083334985121153
Investigators.5141250083145284118145168184222255277314335362376
J910125008325
Am95512500834199
Coll10741250083407793109
Cardiol.12031250083407394132147185201214
Jan14381250083245694
1995;25(1):231-8.155212500833565100134145180215233265279291326361392411447460
doi:10.1016/0735-1097(94)00345-q.3401350083387692104134165178208240272303328362394428461483514546581614630663699716751787820856889911951964
27.3401450085367180
Bangalore43414500833568106145178193231253287
S,73414500833346
Steg7931450083335488127
G,93414500834457
Deedwania100514500834580116155207239277293325
P,134314500833540
et139614500833457
al.14661450083324860
beta-Blocker15401450083397497129152189205243275306340361
use19151450083376398
and34015500833169107
clinical459155008331466198112144176191
outcomes6621550083377496126163220254281
in95515500831452
stable10191550083264880119134168
outpatients12001550083377496135167188203237275296323
with15351550083506587124
and167215500833168107
without17911550083506587125162199221
coronary3401650083326992130169202224259
artery6201650083325479114135170
disease.8111650083395581117150177213225
JAMA.105716500832566122165180
Oct125816500834882106
31385165008335
2012;308(13):1340-9.144116500833570102133146182217253273305336353366396427463500524560571
doi:10.1001/jama.2012.12559.3401750083387692104134165178208240276308330346378436468481517551583613626656686721754786797
28.3401850085377491
Sabido45218500833367107124164203
M,67618500835670
Thilo7671850083347490106145
H,93318500834559
Guido101318500834584100140179
G.121318500834560
Long-term129418500833270110150173196231253313
effectiveness16291850083345574109143168184218253292328356383
of34019500833757
bisoprolol4171950083395581119159181218234273289
in72619500831553
patients7991950083397294110144183204232
with10521950083506689127
angina:119919500833271110125163195208
A1427195008341
real-world14841950083205486102124176214236252291
evidence1795195008334678312215719534020500833165
study.4222050083265088127159169
Pharmacol60820500833573105126184217249286302
Res.9272050083367197111
Jan10552050083255795
2019;139:106-112.116720500833468100130143173203237250279311347370401429458471
doi:10.1016/j.16552050083387792104134165178209240272303328344357
phrs.2018.10.031.3402150083397798126139175209241272286316348360395429459469
29.2140550085367285
Law22405500833165116
MR,23705500835490104
Morris24885500835593115136152178
JK,2680550083246075
Wald27695500835789104143
NJ.2926550083457082
Use30225500834470105
of31415500833757
blood3212550083385492131171
pressure3397550083386094121147185206240
lowering365155008315531041392140650083213673112
drugs2265650083375896135161
in24386500831552
the2503650083215994
prevention2609650083396094126160197219234271309
of29316500833756
cardiovascular3000650083316384122137174206238265296334349381402
disease:3414650083385379113145171206218
meta-36456500835791113146167
-analysis2140750083215390122137168195210235
of23887500833756
1472457750083346496
randomised2565750083215391130167225240266300339
trials291775008321425889104130
in30607500831452
the3124750083225994
context32317500833167105126160191215
of34587500833756
expectations3527750083346510413917119522724926421408500833776102
from2257850083194178136
prospective2409850083386097124163198231255270303337
epidemiological2761850083347489128163221236274290328367383415447463
studies.3239850083264987126142176203217
BMJ.34718500833590116129
May36158500835487118
1937488500833464
2009;338:b1665.21409500833468104140152187220255267306336367403437449
doi:10.1136/bmj.b1665.2604950083387692104134165178209236266301326366424439452492523554589623635
30.21401050085377693
Smith226010500833394111136177
C,246410500834156
Teitler25471050083336784108126163186
M.276110500835672
Beta-blocker28601050083367498134158201219259295327364387
selectivity32741050083276582120155181198233251276312
at361310500833357
cloned36971050083324990214011500833977120
human230011500833980142178219
beta255911500834079104141
1-273911500833557
and283611500833374117
beta299311500833978104140
2-adrenergic31731150083355894137161199240279303345363398
receptors.3611115008321599513217521401250083226388119136
Cardiovasc232112500834178103145163205241278308344
Drugs271012500834772114157187
Ther.294212500833477116141154
Apr314112500834286111
1999;13(2):123-6.329712500833569108147163197231252290312327360394433458499516
doi:10.1023/a:1007784109255.21401350083387793106136169182213245279314339371383414446483516551586623654686722756791824837
31.21401450085366981
Ceconi223414500834074106143181196
C,244314500834053
Francolini25091450083325285123155192208223261276
G,279814500834357
Olivares28681450083466377110143164198225
A,310614500834155
et317414500833456
al.32431450083324760
Angiotensin-converting33161450083417911813317119322626429130534336639943647421401550083316587111126164202
enzyme235515500833472101135193228
(ACE)25951550083196099131151
inhibitors27581550083155390105144159182218240267
have303715500833870101135
different3185155008338537291125146180218239
selectivity34371550083266176111143167182214230252286
for37351550083195677
bradykinin21401650083385991129159189205242256293
binding24451650083385289127142178216
sites2673165008326406194120
of280516500833655
human287216500833773129161198
somatic308216500832562119150171186217
ACE.331116500834078110122
Eur34451650083326788
J3545165008323
Pharmacol.3580165008335711021231792112140175008331688396
Dec224917500834580113
22237417500833469
2007;577(1-3):1-6.245617500833468103136145180213248264295314346363375404423460473
doi:10.1016/j.ejphar.2007.07.061.29421750083387591103132163176206238269300325341354388404442481513534544580613649682688723755761796831861871
32.21401850085356985
Fox22371850083326898
KM,234718500833490103
Investigators24621850083155282116142164179217249270306327353
EUtOrocewPiscAd.28271850083337597144165202234267317352366391423464502515
Efficacy3354185008332496784115148179212
of357818500833655
perindopril36451850083387394109146214019500833876116137153168
in232119500831452
reduction23861950083205494131163187202240279
of267819500833756
cardiovascular27471950083316485123138176208240267299337352384405
events316519500833466100138159187
among336519500833289127166205
patients35831950083387193108142180202229
with21402050083516689127
stable22812050083265082122138172
coronary24682050083316890127165198219253
artery27352050083325378112133167
disease:29172050083385379114146172207220
randomised,31512050083215492131169227243269304343356
double-blind,35212050083397711515417020522826821402150083153068107119
placebo-controlled,22762150083395587119153192231254288325363385406444460475509549562
multicentre285521500835795110132148180213251273294328
trial3200215008322435991106
(the33232150083194078113
EUROPA345321500833376112160196233
study).370321500832649873940550083387089100
Lancet.40605500833266104136170193206
Sep42875500833268107
6441555008334
2003;362(9386):782-8.44705500833468105138150185220253271304337371407425437471504538559595608
doi:10.1016/s01406736(03)14286-9.509955008338779210513516617921024227430533035539042245348939406500833467101136155188222239269300333366402425460471
33.3940750085367186
Bertrand4042750083357192116138171209248
ME,43067500835488101
Ferrari4423750083326687109142163179
R,46187500833549
Remme46837500833570128186221
WJ,4920750083587991
et50277500833456
al.5099750083324760
Perindopril5175750083356990106144183221260282298313
and55047500833270109
beta-blocker3940850083397496129152192208246278309343364
for4320850083195678
the4414850083226095
prevention4525850083396195127161199221236274313
of48548500833757
cardiac4927850083316485123138170203
events51468500833466101139160188
and53508500833270109
mortality54758500835896118394095008322547085107141
in40959500831553
stable4162950083265082122137172
coronary4349950083316889127165197219253
artery4616950083325378111133167
disease4797950083385379114146173208
patients:5019950083397294109144182203231243
A527795008341
EUropean5333950083337697134174210241279
trial3940105008322435890105
on405810500833775
Reduction414610500833569109146178202217254293
Of445110500834767
cardiac45311050083316384122137169201
events474410500833466100138159187
with49431050083516688126
Perindopril50821050083356889104142181218258279294309
in540410500831552
stable54691050083264981120394011500831549
coronary40021150083316889126164196217251
Artery42651150083416287120141175
disease44531150083375278113144171205
(EUROPA)46711150083195194130177213250269
subanalysis.495211500832663102135173205220251278293319332
Am529711500834098
Heart540811500834378110131155
J.557611500832436
Dec394012500834581113
2015;170(6):1092-8.406912500833468100130140171200233253286304316346377412445466502515
doi:10.1016/j.ahj.2015.08.018.45991250083397792104134166178209240272303328345358391430445458494528560590602637672686721752783797
34.39401350085367489
Brugts40501350083365796135158186
JJ,42571350083244961
Bertrand43391350083357192117139172211250
M,461013500835568
Remme469913500833671130188223
W,494313500835868
et503213500833456
al.51091350083324861
The519113500833272108
Treatment53191350083335085117139198233272294
Effect39401450083325170104137161
of411314500833756
an418214500833269
ACE-Inhibitor426414500834180112133150187225240279294316353374
Based46511450083356894129168
Regimen483214500833570109124181216254
with50991450083506588125
Perindopril52371450083356889105142181219258280295310
in556014500831452
Relation39401550083357086118140155193232
to418515500832158
Beta-Blocker42571550083357092125148185201239271301336357
use46271550083376398
in473915500831452
29,46348041550083356979114150184
Patients50011550083356789104139177198226
with52401550083516689127
Vascular53801550083366794126164179211232
Disease:39401650083456187122154180215228
a4184165008332
Combined423116500834077136175190228263303
Analysis455016500834179112127159186201227
of479316500833757
Individual48661650083155392107140155194232264280
Data51621650083457899132
of531116500833756
ADVANCE,53841650083408612216120639401750083397184
EUROPA403617500833274109156191228
and427617500833168107
PROGRESS439517500833468115159195227260292
Trials.4699175008332496495110135148
Cardiovasc48591750083397192129144181212244270301
Drugs517217500834566103141167
Ther.535117500833270105125135
Aug549817500834077115
2017;31(4):391-400.394018500833468100129139174205220253271282318351383402438474510523
doi:10.1007/s10557-017-6747-9.44781850083387692104134165178209240276309329353383415449481515533570602632650687720751783801836847
35.39401950085367186
Castellano40431950083407399122156172187219257295
JM,43561950083247992
Pocock446619500833572104141174204
SJ,46871950083335870
Bhatt477419500833574106128152
DL,49431950083467892
et505219500833456
al.51261950083324760
Polypill52031950083357288120160175191206
Strategy54261950083335475108130164394020500833871
in403120500831553
Secondary410520500833268101138176216248270304
Cardiovascular44302050083407394132148186218251278311349364397418
Prevention.48692050083355690123157195217233271310323
N5213205008344
Engl527820500833371110126
J5424205008325
Med.546920500835590130143
Sep394021500833268107
15406221500833464
2022;387(11):967-977.414221500833468101135148183217250267298326340352387423456474509542577583
doi:10.1056/NEJMoa2208275.47402150083387692104134165178208240274308333379412439494532565600635669704738771803815
INTERVENČNÍ341804001071978123168215263308366420478499
A8628040010752
AKUTNÍ936804001075299157202263284
KARDIOLOGIE12418040010745103150211232295337397456477520
/18078040010732
Interv188480400107196794136163207
Akut2111804001075290139167
Kardiol.2297804001074588114162181229249264
2024;23(2-3):96-1022581804001074487128168183227271293336361402423438482527557595635676
/33028040010732
Využíváme510767001254482125160180218258324363
systém892767001253069100130168235
CrossRef.114576700129427712716420125530233714807670012520
S15197670012538
články157576700125325493136175214
můžete18087670012565108142181209248
snadno2075767001253074113156199241
pracovat2334767001254270110142183220260287
díky2640767001254262103143
jednoznačnému2801767001252059103147188222266305337382421487530
identikátoru3350767001251962101145173194239278317345386413457
DOI.3826767001295410713739627670012520
S51067300450155
NÁMI72467300450163322543631
SE141367300450155283
NEZTRATÍTE1754673004501632884165647318901027111812611391
Časopis5107130020465135188260333370423
je9647130020435103
indexován10977130020435110184252317387450518593
v17207130020464
těchto18147130020449115170246295365
databázích:22097130020472141190259333402460496550626660
Scopus,5107320020464119190263338392429
Ebsco,9697320020464136190245315350
Embase13497320020464175249318371440
a18197320020468
Bibliographia19177320020477112186224259331404452521594670706774
medica272173200204111180254290344414
čechoslovaca31667320020453120175251322376413483547615669739